DALE BRADLEY: Open Payments
NPI 1588607428 · TYLER, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,288 in 216 payments from 25 companies in 2025. Trend: 2023 $3,152 · 2024 $3,782 · 2025 $3,288
Food & beverage: $3,284Education: $4
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 23 | $379 |
| Bayer Healthcare Pharmaceuticals Inc. | 20 | $308 |
| ABBVIE INC. | 25 | $292 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 13 | $264 |
| Lundbeck LLC | 12 | $240 |
| PFIZER INC. | 21 | $222 |
| Vanda Pharmaceuticals Inc. | 10 | $216 |
| Novartis Pharmaceuticals Corporation | 26 | $211 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 14 | $191 |
| Lilly USA, LLC | 9 | $151 |
Products named: Kerendia, CAPLYTA, REXULTI, FANAPT, LEQVIO, JARDIANCE, FARXIGA, VRAYLAR.
Industry payments across TX — which companies pay providers there.
